Yes, Atypical HUS Can Cause Schistocytes on Peripheral Blood Smear
Atypical hemolytic uremic syndrome (aHUS) characteristically causes schistocytes on peripheral blood smear as part of the microangiopathic hemolytic anemia that defines this thrombotic microangiopathy. 1
Schistocytes as a Diagnostic Feature
According to the most recent 2025 Italian multidisciplinary consensus guidelines, aHUS is characterized by microangiopathic hemolysis, which includes:
- Non-immune hemolytic anemia (negative direct Coombs test)
- Elevated LDH levels
- Reduced haptoglobin levels
- With or without the presence of schistocytes in peripheral blood smear 1
Critical Diagnostic Threshold
Schistocytes >1% on peripheral blood smear represent a robust cytomorphological threshold that favors a diagnosis of thrombotic microangiopathy 1. This finding, when present alongside thrombocytopenia and renal involvement, strongly supports the diagnosis of aHUS after excluding other causes.
Important Clinical Caveat
The absence of schistocytes should NOT exclude an earlier diagnosis of thrombotic microangiopathy or aHUS 1. This is a critical pitfall to avoid because:
- The test for schistocytes has low sensitivity 1
- Schistocytes may appear later in the disease course (delayed-onset hemolysis has been documented) 2
- Not all three classic features (hemolytic anemia, thrombocytopenia, renal involvement) may be clearly present at onset 1
Recent Case Evidence
Multiple 2026 case reports confirm schistocyte presence in aHUS:
- A 32-year-old woman with CFH mutation-positive aHUS had schistocytes on peripheral blood smear consistent with TMA 3
- A 50-year-old woman developed schistocytes on Day 9 of admission, demonstrating delayed-onset hemolysis in HUS 2
- A 29-year-old postpartum woman showed >10 schistocytes per high-power field in pregnancy-associated HUS 4
- Schistocytes were even detected in urine sediment in a case of aHUS, representing the first such report and demonstrating the severity of glomerular microangiopathy 5
Diagnostic Algorithm When Schistocytes Are Present
When you identify schistocytes with anemia and thrombocytopenia:
- Immediately check ADAMTS13 activity (urgently if TMA suspected) - severely deficient (<10 IU/dL) indicates TTP, not aHUS 1
- Test stool for verocytotoxin-producing E. coli (VTEC) to exclude typical (STEC) HUS 1
- Assess renal involvement: hematuria, proteinuria, elevated creatinine 1
- Confirm hemolysis markers: elevated LDH, reduced haptoglobin, negative direct Coombs test 1
The presence of schistocytes in the appropriate clinical context (thrombocytopenia, hemolytic anemia, renal dysfunction) with ADAMTS13 activity >10% and negative STEC testing supports the diagnosis of aHUS and warrants consideration of complement inhibition therapy with eculizumab or ravulizumab 1, 3.